ATE539749T1 - Dextromethorphan für die behandlung von akne - Google Patents

Dextromethorphan für die behandlung von akne

Info

Publication number
ATE539749T1
ATE539749T1 AT06751392T AT06751392T ATE539749T1 AT E539749 T1 ATE539749 T1 AT E539749T1 AT 06751392 T AT06751392 T AT 06751392T AT 06751392 T AT06751392 T AT 06751392T AT E539749 T1 ATE539749 T1 AT E539749T1
Authority
AT
Austria
Prior art keywords
treatment
patient
administering
compound
effective amount
Prior art date
Application number
AT06751392T
Other languages
English (en)
Inventor
Hua-Lin Wu
Guey-Yueh Shi
Chuan-Chi Chiang
Hui-Pin Su
Original Assignee
Blue Blood Biotech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blue Blood Biotech Corp filed Critical Blue Blood Biotech Corp
Application granted granted Critical
Publication of ATE539749T1 publication Critical patent/ATE539749T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT06751392T 2006-02-24 2006-04-26 Dextromethorphan für die behandlung von akne ATE539749T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/361,589 US7939567B2 (en) 2006-02-24 2006-02-24 Dextromethorphan-based method for treating acne
PCT/US2006/015661 WO2007097765A1 (en) 2006-02-24 2006-04-26 Methods and compositions for bactericide, bacteriostatic and anti-inflammation

Publications (1)

Publication Number Publication Date
ATE539749T1 true ATE539749T1 (de) 2012-01-15

Family

ID=38437685

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06751392T ATE539749T1 (de) 2006-02-24 2006-04-26 Dextromethorphan für die behandlung von akne

Country Status (13)

Country Link
US (1) US7939567B2 (de)
EP (1) EP1986620B1 (de)
JP (1) JP5347195B2 (de)
KR (1) KR101279196B1 (de)
CN (1) CN101023947B (de)
AT (1) ATE539749T1 (de)
AU (1) AU2006338583B8 (de)
BR (1) BRPI0621210A2 (de)
CA (1) CA2643277A1 (de)
IL (1) IL193628A0 (de)
TW (1) TWI365743B (de)
WO (1) WO2007097765A1 (de)
ZA (1) ZA200806703B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8461102B2 (en) * 2010-03-02 2013-06-11 George E. Royster, JR. Methods and compositions for treating and preventing symptoms of hormonal variations
KR20130061148A (ko) * 2010-05-03 2013-06-10 티에스에이치 바이오팜 코포레이션 리미티드 고혈압 치료용 약학 조성물 및 방법
CN102471770B (zh) * 2010-05-27 2013-07-24 莲见贤一郎 抗原肽及其用途
EP2736512B1 (de) * 2011-07-28 2021-06-30 Ian S. Zagon Verfahren und zusammensetzungen zur behandlung von epithelwunden
US20150352100A1 (en) * 2013-01-21 2015-12-10 Avant Derma Pte. Ltd. Use of selective delta-opioid receptor antagonists and specific sensory receptor ligands
US9649266B2 (en) 2014-05-01 2017-05-16 Anterios, Inc. Methods to treat, prevent, and improve skin conditions
JP2019535829A (ja) 2016-11-21 2019-12-12 エイリオン セラピューティクス， インコーポレイテッド 大型薬剤の経皮送達
CN106801037B (zh) * 2017-01-06 2021-01-19 中国人民解放军南京军区福州总医院 体外痤疮炎症模型的建立方法及其应用
US20230241029A1 (en) * 2018-12-11 2023-08-03 Kristoffer Hellstrand Methods of reducing post-surgical metastasis
CN114409673B (zh) * 2022-01-04 2023-08-08 广东克冠达医药科技有限公司 一种吗啡喃类化合物及其制备方法与应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2676177A (en) * 1949-11-09 1954-04-20 Hoffmann La Roche Process for the preparation of optically active 3-methoxy-n-methyl morphinans and salts thereof
CA1214393A (en) * 1984-06-26 1986-11-25 Eric L. Nelson Composition useful in the treatment of diarrhea
CA2064331C (en) * 1991-03-28 2003-02-18 Marvin L. Bayne Vascular endothelial cell growth factor c subunit
US5206248A (en) * 1992-03-27 1993-04-27 Smith Richard A Method for reducing emotional lability
US5366980A (en) * 1991-06-17 1994-11-22 Smith Richard A Use of dextromethorphan and an oxidase inhibitor to treat dermatitis
US5260066A (en) * 1992-01-16 1993-11-09 Srchem Incorporated Cryogel bandage containing therapeutic agent
US5834480A (en) * 1997-06-13 1998-11-10 Elkhoury; George F. Topical application of opioids for treatment of acne and sebaceous gland disorders
US5994330A (en) * 1998-11-09 1999-11-30 El Khoury; Georges F. Topical application of muscarinic agents such as neostigmine for treatment of acne and other inflammatory conditions
BR0108379A (pt) * 2000-02-08 2002-11-05 Euro Celtique Sa Composições de liberação controlada contendo agonista e antagonista opióide, método para a preparação de uma formulação em dosagem de analgésico opióide de liberação controlada com potência analgésica aumentada e sistema de administração através da derme para um analgésico opióide
CN1200709C (zh) * 2003-01-23 2005-05-11 张以成 氢溴酸右美沙芬滴丸及其制备方法

Also Published As

Publication number Publication date
CN101023947B (zh) 2012-10-31
KR101279196B1 (ko) 2013-06-26
EP1986620B1 (de) 2012-01-04
BRPI0621210A2 (pt) 2011-12-06
IL193628A0 (en) 2009-08-03
AU2006338583B2 (en) 2011-12-22
TW200731972A (en) 2007-09-01
AU2006338583A1 (en) 2007-08-30
CA2643277A1 (en) 2007-08-30
US7939567B2 (en) 2011-05-10
KR20080106183A (ko) 2008-12-04
AU2006338583B8 (en) 2012-01-12
EP1986620A1 (de) 2008-11-05
ZA200806703B (en) 2009-09-30
CN101023947A (zh) 2007-08-29
TWI365743B (en) 2012-06-11
US20070203164A1 (en) 2007-08-30
JP5347195B2 (ja) 2013-11-20
JP2009527553A (ja) 2009-07-30
EP1986620A4 (de) 2009-11-25
WO2007097765A1 (en) 2007-08-30

Similar Documents

Publication Publication Date Title
ATE539749T1 (de) Dextromethorphan für die behandlung von akne
RU2010144637A (ru) Замещенные гамма-лактамы в качестве терапевтических агентов
EA200800538A1 (ru) Терапевтические соединения
ATE416177T1 (de) Hetaryloxy-substituierte phenylaminopyrimidine als rho-kinasehemmer
TW200640864A (en) Pyridyl non-aromatic nitrogenated heterocyclic-1-carboxylate ester derivative
HK1125039A1 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
SG159388A1 (en) Antibacterial agents
NO20074999L (no) Metode og preparat for behandling av perifere vaskulaere sykdommer
EP2639229A3 (de) Thiazolderivate und deren Verwendung als VAP-1-Hemmer
MY147864A (en) Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin
MX2011009709A (es) Compuestos para el tratamiento de la inflamacion y del dolor.
SE0200667D0 (sv) Novel use of cytokine inhibitors
MX362830B (es) Agente terapeutico o profilactico para enfermedades del tracto biliar.
MX2009011818A (es) Formulaciones de aminoacido n-halogenado con compuestos anti-inflamatorios.
DE60309465D1 (de) Behandlung oder prävention von urogenitaler atrophie und deren symptomen bei frauen
MY148565A (en) Agent for therapy and/or improvement of disseminated intravascular coagulation
WO2008088987B1 (en) Treatment of pain with naloxone
EA202193211A1 (ru) Лечение синуклеопатий
NZ582328A (en) Pharmaceutical combination of opioid and prostaglandin compound
WO2006076119A3 (en) Treatment of skin diseases
HK1080768A1 (en) Use of epothilone derivatives for the treatment ofhyperparathyroidism
WO2001055108A3 (en) Use of spl a2 inhibitors for the treatment of inflammation
SG124310A1 (en) Treatment of skin diseases
ATE442848T1 (de) Isoxazolsäure-derivat zur linderung neuropathischer schmerzen
RU2014126635A (ru) Лечение себореи